Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™

NCT02582073 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
265
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergy Therapeutics